Artwork

A tartalmat a Dr. Geo Espinosa biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Dr. Geo Espinosa vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
Player FM - Podcast alkalmazás
Lépjen offline állapotba az Player FM alkalmazással!

Revolutionizing Prostate Cancer Diagnosis: Urine Testing Insights with Dr. David Albala

1:09:24
 
Megosztás
 

Manage episode 430082174 series 3313759
A tartalmat a Dr. Geo Espinosa biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Dr. Geo Espinosa vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

Join Dr. Geo as he interviews Dr. David Albala, Chief of Urology at Crouse Hospital and a renowned expert in laparoscopic and robotic urological surgery. They explore the advancements in prostate cancer diagnosis, emphasizing the shift from routine biopsies based on high PSA levels to more sophisticated methods like urine tests and biomarkers such as free PSA, ExoDx, and 4Kscore. Dr. Albala shares his experiences and insights on the benefits and limitations of these tests, reflecting on how telemedicine and technological advancements are improving patient outcomes.

In this episode, Dr. Albala discusses the evolution of prostate cancer surgeries from open and laparoscopic to robotic techniques, highlighting the importance of minimally invasive procedures. He emphasizes the role of patient education and shared decision-making in prostate cancer treatment, sharing his reflections on his career and contributions to the field.

----------------

Thank you to our July Sponsors:

The Decipher Test: The Decipher Prostate Test by Veracyte analyzes specific genes in a prostate tumor to assess cancer aggressiveness, aiding in personalized treatment decisions and improving patient outcomes. Learn more about the Decipher Prostate Test here [https://bit.ly/4cNH805].

ExoDx: The ExoDx Prostate Score is a non-invasive urine test for assessing the risk of aggressive prostate cancer, using cancer-specific genomic biomarkers. Scores below 15.6 indicate low risk, while scores above 15.6 indicate higher risk. Decisions on further actions, such as biopsies, should involve shared decision-making between the doctor and patient. Learn more about ExoDx here [https://bit.ly/3oA8rXC].

XY Wellness: XY Wellness provides a high-value roadmap to health and wellness for men with prostate cancer. Co-founded by our Chief Medical Officer, they aim to help men thrive post-diagnosis. [Learn more about XY Wellness here [https://bit.ly/3uJPC7Z].

----------------

Thanks for listening to this week's episode. Subscribe to The Dr. Geo YouTube Channel to get more content like this and learn how you can live better with age.

You can also listen to this episode and future episodes of the Dr. Geo Podcast by clicking HERE.

----------------

Follow Dr. Geo on social media. Facebook, Instagram Click here to become a member of Dr. Geo’s Health Community.

Improve your urological health with Dr. Geo’s formulated supplement lines:XY Wellness for Prostate cancer lifestyle and nutrition: Mr. Happy Nutraceutical Supplements for prostate health and male optimal living.

You can also check out Dr. Geo’s online dispensary for other supplement recommendations Dr. Geo’s Supplement Store

____________________________________

DISCLAIMER: This audio is educational and does not constitute medical advice. This audio's content is my opinion and not that of my employer(s) or any affiliated company.

Use of this information is at your own risk. Geovanni Espinosa, N.D., will not assume any liability for any direct or indirect losses or damages that may result from the use of the information contained in this video, including but not limited to economic loss, injury, illness, or death.

  continue reading

118 epizódok

Artwork
iconMegosztás
 
Manage episode 430082174 series 3313759
A tartalmat a Dr. Geo Espinosa biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Dr. Geo Espinosa vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

Join Dr. Geo as he interviews Dr. David Albala, Chief of Urology at Crouse Hospital and a renowned expert in laparoscopic and robotic urological surgery. They explore the advancements in prostate cancer diagnosis, emphasizing the shift from routine biopsies based on high PSA levels to more sophisticated methods like urine tests and biomarkers such as free PSA, ExoDx, and 4Kscore. Dr. Albala shares his experiences and insights on the benefits and limitations of these tests, reflecting on how telemedicine and technological advancements are improving patient outcomes.

In this episode, Dr. Albala discusses the evolution of prostate cancer surgeries from open and laparoscopic to robotic techniques, highlighting the importance of minimally invasive procedures. He emphasizes the role of patient education and shared decision-making in prostate cancer treatment, sharing his reflections on his career and contributions to the field.

----------------

Thank you to our July Sponsors:

The Decipher Test: The Decipher Prostate Test by Veracyte analyzes specific genes in a prostate tumor to assess cancer aggressiveness, aiding in personalized treatment decisions and improving patient outcomes. Learn more about the Decipher Prostate Test here [https://bit.ly/4cNH805].

ExoDx: The ExoDx Prostate Score is a non-invasive urine test for assessing the risk of aggressive prostate cancer, using cancer-specific genomic biomarkers. Scores below 15.6 indicate low risk, while scores above 15.6 indicate higher risk. Decisions on further actions, such as biopsies, should involve shared decision-making between the doctor and patient. Learn more about ExoDx here [https://bit.ly/3oA8rXC].

XY Wellness: XY Wellness provides a high-value roadmap to health and wellness for men with prostate cancer. Co-founded by our Chief Medical Officer, they aim to help men thrive post-diagnosis. [Learn more about XY Wellness here [https://bit.ly/3uJPC7Z].

----------------

Thanks for listening to this week's episode. Subscribe to The Dr. Geo YouTube Channel to get more content like this and learn how you can live better with age.

You can also listen to this episode and future episodes of the Dr. Geo Podcast by clicking HERE.

----------------

Follow Dr. Geo on social media. Facebook, Instagram Click here to become a member of Dr. Geo’s Health Community.

Improve your urological health with Dr. Geo’s formulated supplement lines:XY Wellness for Prostate cancer lifestyle and nutrition: Mr. Happy Nutraceutical Supplements for prostate health and male optimal living.

You can also check out Dr. Geo’s online dispensary for other supplement recommendations Dr. Geo’s Supplement Store

____________________________________

DISCLAIMER: This audio is educational and does not constitute medical advice. This audio's content is my opinion and not that of my employer(s) or any affiliated company.

Use of this information is at your own risk. Geovanni Espinosa, N.D., will not assume any liability for any direct or indirect losses or damages that may result from the use of the information contained in this video, including but not limited to economic loss, injury, illness, or death.

  continue reading

118 epizódok

Minden epizód

×
 
Loading …

Üdvözlünk a Player FM-nél!

A Player FM lejátszó az internetet böngészi a kiváló minőségű podcastok után, hogy ön élvezhesse azokat. Ez a legjobb podcast-alkalmazás, Androidon, iPhone-on és a weben is működik. Jelentkezzen be az feliratkozások szinkronizálásához az eszközök között.

 

Gyors referencia kézikönyv